Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study

被引:1
|
作者
Tang, Xin [1 ]
Shi, Rui [1 ]
Jiang, Li [1 ]
Yan, Wei-Feng [1 ]
Han, Pei-Lun [1 ]
Qian, Wen-Lei [1 ]
Yang, Zhi-Gang [1 ]
Li, Yuan [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Radiol, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
关键词
Type 2 diabetes mellitus; Metabolic-associated fatty liver disease; Cardiac magnetic resonance; Left ventricular function; Global peak strain; LATE GADOLINIUM ENHANCEMENT; NONISCHEMIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; RISK; OUTCOMES; QUANTIFICATION; STEATOSIS; MAFLD;
D O I
10.1186/s12933-024-02410-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundType 2 diabetes mellitus (T2DM) and metabolic-associated fatty liver disease (MAFLD) are both metabolic disorders that negatively impact the cardiovascular system. This study comprehensively analyzed the additive effect of MAFLD on left ventricular function and global strain in T2DM patients by cardiac magnetic resonance (CMR).MethodsData of 261 T2DM patients, including 109 with and 152 without MAFLD, as well as 73 matched normal controls from our medical center between June 2015 and March 2022 were retrospectively analyzed. CMR-derived parameters, including LV function and global strain parameters, were compared among different groups. Univariate and multivariate linear regression analyses were conducted to investigate the impact of various factors on LV function and global strain.ResultsOur investigation revealed a progressive deterioration in LV functional parameters across three groups: control subjects, T2DM patients without MAFLD, and T2DM patients with MAFLD. Statistically significant increases in left ventricular end-diastolic volume index (LVEDVI), left ventricular end-systolic volume index (LVESVI), left ventricular mass index (LVMI) were observed, along with decreases in left ventricular ejection fraction (LVEF) and left ventricular global function index (LVGFI). Among these three groups, significant reductions were also noted in the absolute values of LV global radial, circumferential, and longitudinal peak strains (GRPS, GCPS, and GLPS), as well as in peak systolic (PSSR) and peak diastolic strain rates (PDSR). MAFLD was identified as an independent predictor of LVEF, LVMI, LVGFI, GRPS, GCPS, and GLPS in multivariate linear analysis. Besides, the incidence of late gadolinium enhancement was higher in MAFLD patients than in non-MAFLD patients (50/109 [45.9%] vs. 42/152 [27.6%], p = 0.003). Furthermore, escalating MAFLD severity was associated with a numerical deterioration in both LV function parameters and global strain values.ConclusionsThis study thoroughly compared CMR parameters in T2DM patients with and without MAFLD, uncovering MAFLD's adverse impact on LV function and deformation in T2DM patients. These findings highlight the critical need for early detection and comprehensive management of cardiac function in T2DM patients with MAFLD.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] The worsening effect of anemia on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T CMR feature tracking study
    Qian, Wen-Lei
    Xu, Rong
    Shi, Rui
    Li, Yuan
    Guo, Ying-Kun
    Fang, Han
    Jiang, Li
    Yang, Zhi-Gang
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [2] The worsening effect of anemia on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T CMR feature tracking study
    Wen-Lei Qian
    Rong Xu
    Rui Shi
    Yuan Li
    Ying-Kun Guo
    Han Fang
    Li jiang
    Zhi-Gang Yang
    Cardiovascular Diabetology, 22
  • [3] The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study
    Li, Xue-Ming
    Yan, Wei-Feng
    Shi, Ke
    Shi, Rui
    Jiang, Li
    Gao, Yue
    Min, Chen-Yan
    Liu, Xiao-Jing
    Guo, Ying-Kun
    Yang, Zhi-Gang
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [4] A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
    Efrem, Ion Cristian
    Mota, Maria
    Vladu, Ionela Mihaela
    Mitrea, Adina
    Clenciu, Diana
    Timofticiuc, Diana Cristina Protasiewicz
    Diaconu, Ileana-Diana
    Turcu, Adina
    Crisan, Anda Elena
    Geormaneanu, Cristiana
    Glodeanu, Adina Dorina
    Mahler, Beatrice
    Tudor, Marinela Sinziana
    Amzolini, Anca Maria
    Micu, Simona Elena
    Abu Alhija, Anca Barau
    Mita, Adrian
    Filip, Maria Monalisa
    Fortofoiu, Maria
    DIAGNOSTICS, 2022, 12 (10)
  • [5] The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study
    Xue-Ming Li
    Wei-Feng Yan
    Ke Shi
    Rui Shi
    Li Jiang
    Yue Gao
    Chen-Yan Min
    Xiao-Jing Liu
    Ying-Kun Guo
    Zhi-Gang Yang
    Cardiovascular Diabetology, 23
  • [6] The additive effect of metabolic syndrome on left ventricular impairment in patients with obstructive coronary artery disease assessed by 3.0 T cardiac magnetic resonance feature tracking
    Min, Chen-Yan
    Gao, Yue
    Jiang, Yi-Ning
    Guo, Ying-Kun
    Shi, Ke
    Yang, Zhi-Gang
    Li, Yuan
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [7] Association of Metabolic Dysfunction-Associated Fatty Liver Disease With Left Ventricular Diastolic Function and Cardiac Morphology
    Peng, Dandan
    Yu, Zhenqiu
    Wang, Mingwei
    Shi, Junping
    Sun, Lei
    Zhang, Yuanyuan
    Zhao, Wenbin
    Chen, Chen
    Tang, Jiake
    Wang, Chunyi
    Ni, Jie
    Wen, Wen
    Jiang, Jingjie
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes
    Mantovani, Alessandro
    Csermely, Alessandro
    Taverna, Antonio
    Cappelli, Davide
    Benfari, Giovanni
    Bonapace, Stefano
    Byrne, Christopher D.
    Targher, Giovanni
    DIABETES & METABOLISM, 2023, 49 (02)
  • [9] Association of metabolic dysfunction-associated fatty liver disease, type 2 diabetes mellitus, and metabolic goal achievement with risk of chronic kidney disease
    Su, Weitao
    Chen, Minhui
    Xiao, Ling
    Du, Shanshan
    Xue, Lihua
    Feng, Ruimei
    Ye, Weimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [10] Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes
    Cernea, Simona
    Onisor, Danusia
    Roiban, Andrada Larisa
    Benedek, Theodora
    Rat, Nora
    WORLD JOURNAL OF CARDIOLOGY, 2024, 16 (10):